Literature DB >> 12071512

Regulation of ER stress proteins by valproate: therapeutic implications.

Christopher D Bown1, Jun-Feng Wang, Biao Chen, L Trevor Young.   

Abstract

OBJECTIVES: This paper reviews results of our studies examining the regulation of endoplasmic reticulum (ER) stress proteins by valproate (VPA). and discusses the possible implications in bipolar disorder.
METHODS: Our previous studies in the field are reviewed along with relevant literature.
RESULTS: Using differential display PCR, we identified GRP78 as a VPA-regulated gene in rat cerebral cortex. We also showed that other members of the ER stress proteins family, GRP94 and calreticulin, are also upregulated by VPA. Immunohistochemistry identified that ER stress proteins are increased in frontal and parietal cortex, as well as regions of the hippocampus in rat brain following chronic treatment with VPA.
CONCLUSIONS: Regulation of ER stress proteins by VPA may prove to be important to the mechanism of action of the drug. The neuroprotective role of these proteins may also prove to be involved in the pathophysiology of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071512     DOI: 10.1034/j.1399-5618.2002.t01-1-40201.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  17 in total

1.  Decreased gene expression activity as a result of a mutation in the calreticulin gene promoter in a family case of schizoaffective disorder.

Authors:  S Farashi; M Ohadi; S Hosseinkhani; H Darvish; A Mirabzadeh
Journal:  Cogn Neurodyn       Date:  2015-11-27       Impact factor: 5.082

Review 2.  A review of the mammalian unfolded protein response.

Authors:  Anirikh Chakrabarti; Aaron W Chen; Jeffrey D Varner
Journal:  Biotechnol Bioeng       Date:  2011-08-09       Impact factor: 4.530

Review 3.  The unfolded protein response triggered by environmental factors.

Authors:  Masanori Kitamura
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

Review 4.  Role of endoplasmic reticulum stress in metabolic disease and other disorders.

Authors:  Lale Ozcan; Ira Tabas
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

Review 5.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic X. laevis Models of Retinitis Pigmentosa.

Authors:  Ruanne Y J Vent-Schmidt; Runxia H Wen; Zusheng Zong; Colette N Chiu; Beatrice M Tam; Christopher G May; Orson L Moritz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

7.  Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience.

Authors:  Joshua G Hunsberger; Rodrigo Machado-Vieira; Daniel R Austin; Carlos Zarate; De-Maw Chuang; Guang Chen; John C Reed; Husseini K Manji
Journal:  Brain Res       Date:  2011-06-12       Impact factor: 3.252

Review 8.  Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.

Authors:  M G Soeiro-de-Souza; V V Dias; M L Figueira; O V Forlenza; W F Gattaz; C A Zarate; R Machado-Vieira
Journal:  Acta Psychiatr Scand       Date:  2012-06-08       Impact factor: 6.392

9.  Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.

Authors:  Xuejing Wang; Mingming Ma; Junfang Teng; Xiangqian Che; Wenwen Zhang; Shuman Feng; Shuang Zhou; Ying Zhang; Erxi Wu; Xuebing Ding
Journal:  Int J Biol Sci       Date:  2015-05-19       Impact factor: 6.580

Review 10.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.